Soukupová Marie, Palazzo Enza, De Chiaro Maria, Gatta Luisa, Migliozzi Anna Lucia, Guida Francesca, Luongo Livio, Giordano Catia, Siniscalco Dario, De Novellis Vito, Marabese Ida, Krsiak Miloslav, Maione Sabatino
Department of Pharmacology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic.
Neuro Endocrinol Lett. 2010;31(4):507-11.
Paracetamol is converted to an active metabolite AM404 via fatty acid amide hydrolase (FAAH). The aim of the present study was to ascertain whether a FAAH inhibitor URB597 antagonizes paracetamol analgesic activity (and to asses by this way the role of FAAH in analgesic activity of paracetamol).
The interaction between a FAAH inhibitor URB597 and paracetamol was investigated in the writhing test in mice using an isobolographic analysis.
URB597 or paracetamol alone and in combinations produced dose-dependent antinociceptive effects. ED50 values were estimated for the individual drugs and an isobologram was constructed. The observed ED50 value for the URB57-paracetamol combination was 0.097 (0.062-0.247) mg/kg. This value did not differ significantly from the theoretical additive ED50 value for the URB597-paracetamol combination which was 0.108 (0.059-0.198) mg/kg. Thus, inhibition of FAAH by URB597 was not followed by the lack of analgesic activity in paracetamol.
The present results suggest that the analgesic activity of paracetamol is not dependent solely on FAAH metabolic conversion to AM404 and that paracetamol exerts analgesic activity also by additional mechanisms.